User Evaluation of the Invasive Component of the CNOGA TensorTip COMBO GLUCOMETER (CoG)
NCT ID: NCT03870971
Last Updated: 2020-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
543 participants
INTERVENTIONAL
2019-02-04
2019-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of CoG by Patients With Diabetes Mellitus
NCT03840161
Dexcom G6 Intervention Study
NCT03877068
Dexcom G6 Observational Study
NCT03832907
Continuous Glucose Monitoring in Patients With Type 2 Diabetes
NCT00529815
Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm
NCT02087995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood glucose measurement
After the patient has performed the manual reading, the investigator or staff member will obtain another capillary blood sample and a reference reading by means of the YSI 2300 Stat plus analyzer will be performed and recorded. If patients need more than one attempt to get a successful blood glucose reading, the number of attempts will be documented. A questionnaire needs to filled by the participant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who are able to complete informed consent form (by him/herself or by his/her guardian);
* 18 years old and above;
* Subjects with any other severe disease in the discretion of the investigator
* Not capable to read English user instructions at the discretion of the patient
* Pregnancy or Nursing mothers
* Any condition that may prevent participants from successful participation in the trial (in discretion of the investigator)
* Illiteracy
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cnoga Medical Ltd.
INDUSTRY
Sciema UG
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rainier Clinical Research Center, Inc.
Renton, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CNG-NGM-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.